International Patent: GENERATION OF GENETICALLY-MODIFIED DOGS WITH REDUCED ALLERGIC RESPONSE IN HUMANS

GENEVA, Aug. 14 -- CAN9 BIOENGINEERING, INC. filed a patent application (IB2026/051107) for “GENERATION OF GENETICALLY-MODIFIED DOGS WITH REDUCED ALLERGIC RESPONSE IN HUMANS”. With publication no. WO/2026/167593, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 5/077

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....